Nexell To Use Peer-Reviewed Articles To Demonstrate Cytonex Diagnostic Use
This article was originally published in The Gray Sheet
Executive Summary
Nexell Therapeutics plans to use studies published in peer-reviewed journal articles to support marketing efforts for its Cytonex immunocytochemistry (ICC) staining kit for in vitro diagnostic use.
You may also be interested in...
WLF Decision Opens Door To Off-Label Promotion With Journal Reprints
Manufacturers can promote products for off-label uses with studies sponsored by competitors, according to the July 28 federal court decision against the FDA Modernization Act in Washington Legal Foundation v. Henney.
Nexell Planning To Seek Labeling Expansion For Isolex 300i In 2001
Nexell Therapeutics plans to file two premarket approval applications in the second half of 2001 to expand labeling for its Isolex 300i magnetic cell selection system, which gained FDA approval July 6.
Baxter To Distribute Ceprate During Cellpro Bankruptcy Until Isolex Approval
Baxter will distribute Cellpro's Ceprate stem cell concentration system worldwide pending approval of Nexell's Isolex stem cell collection system under a bankruptcy plan for CellPro.